Loading
An trial of Senza5 CART5 run by Vittoria Biotherapeutics, not yet recruiting.
A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials is an interventional study registered as NCT07683897 by Vittoria Biotherapeutics, with 30 participants planned, started 2026-07. Conditions recorded: Participants Treated With Senza5. Interventions recorded: Senza5 CART5.
Shares Senza5 CART5, Vittoria Biotherapeutics and the tag pipeline.
Shares Vittoria Biotherapeutics and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/